학술논문

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Powles, T.Tomczak, P.Park, S.H.Venugopal, B.Ferguson, T.Symeonides, S.N.Hajek, J.Gurney, H.Chang, Y.-H.Lee, J.L.Sarwar, N.Thiery-Vuillemin, A.Gross-Goupil, M.Mahave, M.Haas, N.B.Sawrycki, P.Burgents, J.E.Xu, L.Imai, K.Quinn, D.I.Choueiri, T.K.Ferguson, T.R.Lin, T.-P.Symeonides, S.N.Haas, N.B.Gurney, H.P.Chevreau, C.Burke, J.M.Doshi, G.Melichar, B.Topart, D.Oudard, S.Kopyltsov, E.Hammers, H.-J.Quinn, D.I.Alva, A.Menezes, J.D.J.Silva, A.G.E.Winquist, E.W.Hamzaj, A.Procopio, G.Karaszewska, B.Nowakowska-Zajdel, E.M.Alekseev, B.Y.Gafanov, R.A.Izmailov, A.Semenov, A.Afanasyev, S.G.Lipatov, O.N.Powles, T.B.Srinivas, S.McDermott, D.Kochuparambil, S.T.Davis, I.D.Peltola, K.Sabbatini, R.Chung, J.Shkolnik, M.I.Matveev, V.B.Gajate Borau, P.McCune, S.Hutson, T.E.Dri, A.Sales, S.C.Yeung, C.Alcala Castro, C.M.Bostrom, P.Laguerre, B.Buttigliero, C.de Giorgi, U.Fomin, E.A.Zakharia, Y.Hwang, C.Singer, E.A.Yorio, J.T.Waterhouse, D.Kowalyszyn, R.D.Alfie, M.S.Yanez Ruiz, E.Buchler, T.Kankaanranta, K.Ferretti, G.Kimura, G.Nishimura, K.Masumori, N.Tamada, S.Kato, H.Kitamura, H.Danielewicz, I.Wojcik-Tomaszewska, J.Sala Gonzalez, N.Chiu, K.-Y.Atkins, M.B.Heath, E.Rojas-Uribe, G.A.Gonzalez Fernandez, M.E.Feyerabend, S.Pignata, S.Numakura, K.Cybulska Stopa, B.Zukov, R.Climent Duran, M.A.Maroto Rey, P.J.Montesa Pino, A.Chang, C.-H.Vengalil, S.Waddell, T.S.Cobb, P.W.Hauke, R.Anderson, D.M.Sarantopoulos, J.Gourdin, T.Zhang, T.Jayram, G.Fein, L.E.Harris, C.Beato, P.M.M.Flores, F.Estay, A.Rubiano, J.A.Bedke, J.Hauser, S.Neisius, A.Busch, J.Anai, S.Tsunemori, H.Sawka, D.Sikora-Kupis, B.Arranz, J.A.Delgado, I.Chen, C.-H.Gunderson, E.Tykodi, S.Koletsky, A.Chen, K.Agrawal, M.Kaen, D.L.Sade, J.P.Tatangelo, M.D.Parnis, F.Barbosa, F.M.Faucher, G.Iqbal, N.Marceau, D.Paradis, J.-B.Hanna, N.Acevedo, A.Ibanez, C.Villanueva, L.Galaz, P.P.Durango, I.C.Manneh, R.Kral, Z.Holeckova, P.Hakkarainen, H.Ronkainen, H.Abadie-Lacourtoisie, S.Tartas, S.Goebell, P.J.Grimm, M.-O.Hoefner, T.Wirth, M.Panic, A.Schultze-Seemann, W.Yokomizo, A.Mizuno, R.Uemura, H.Eto, M.Tsujihata, M.Matsukawa, Y.Murakami, Y.Kim, M.Hamberg, P.Marczewska-Skrodzka, M.Szczylik, C.Humphreys, A.C.Jiang, P.Kumar, B.Lu, G.Desai, A.Karam, J.A.Keogh, G.Fleming, M.Zarba, J.J.Leiva, V.E.Mendez, G.A.Harris, S.J.Brown, S.J.Antonio Junior, J.N.Costamilan, R.D.C.Rocha, R.O.Muniz, D.Brust, L.Lalani, A.-K.Graham, J.Levesque, M.Orlandi, F.Kotasek, R.Deville, J.L.Borchiellini, D.Merseburger, A.Rink, M.Roos, F.McDermott, R.Oyama, M.Yamamoto, Y.Tomita, Y.Miura, Y.Ioritani, N.Westgeest, H.Kubiatowski, T.Bal, W.Girones Sarrio, R.Rowe, J.Prow, D.M.Senecal, F.Hashemi-Sadraei, N.Cole, S.W.Kendall, S.D.Richards, D.A.Schnadig, I.D.Gupta, M.
Source
In: The Lancet Oncology. (The Lancet Oncology, 01 September 2022, 23(9):1133-1144)
Subject
Language
English
ISSN
14745488
14702045